AwardedPOLGoodsPLN 2,376,658
Postępowanie w trybie przetargu nieograniczonego na dostawę leków w ramach programu lekowego Aflibercept, Farycymab, Bewacyzumab, Ranibizumab i Dexamethazon
- Published
- Published 27 December 2024
- Deadline
- Closed 27 January 2025
Overview
Przedmiotem zamówienia jest dostawa leków w ramach programu lekowego Aflibercept, Farycymab, Bewacyzumab, Ranibizumab i Dexamethazon w ilości i o parametrach określonych w Załącznikach nr 1.1 – 1.5 do Specyfikacji Warunków Zamówienia.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Estimated value
- PLN 2,376,658
- Procedure
- Open
- Published
- 27 December 2024
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- PLN 2,205,792
- Award date
- 28 February 2025
- Contract period
- — → 23 February 2026
- Abbvie Sp. z o.o
- Asclepios S.A
- Bayer Sp. z o.o.
- Roche Polska Sp. z o.o
- Tramco Sp. z o.o.
- URTICA sp.z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
20 March 2025
Contract Notice
27 December 2024
Contracting authority
Szpital Miejski św. Jana Pawła II w Elblągu
Procuring entityElbląg, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.